Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

HKG:0719 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	8,466	7,956	7,295	6,360	5,949
Other Revenue	-	144.78	207.82	200.54	56.85
Revenue	8,466	8,101	7,503	6,560	6,006
Revenue Growth (YoY)	4.51%	7.97%	14.37%	9.23%	7.13%
Cost of Revenue	6,425	5,779	5,515	4,824	4,244
Gross Profit	2,042	2,321	1,988	1,736	1,762
Selling, General & Admin	1,022	1,287	1,106	929.12	943.96
Research & Development	413.18	419.24	345.66	341.37	298.35
Other Operating Expenses	10.22	92.18	65.31	59.27	60.28
Operating Expenses	1,445	1,809	1,522	1,332	1,303
Operating Income	596.33	512.15	465.87	403.67	458.77
Interest Expense	-	-41.15	-49.71	-53.1	-59.76
Interest & Investment Income	9.84	21.88	18.83	16.79	11.58
Currency Exchange Gain (Loss)	-	15.42	10.53	-4.18	-24.78
Other Non Operating Income (Expenses)	-22.32	-2.72	-3.38	-2.45	-4.46
EBT Excluding Unusual Items	583.85	505.59	442.15	360.72	381.35
Gain (Loss) on Sale of Assets	1.42	8.73	5.54	2.07	2.49
Asset Writedown	-51.61	-10.29	-2.61	-1.88	-4.43
Other Unusual Items	-	28.65	26.7	60.32	32.23
Pretax Income	533.65	532.69	471.77	421.23	411.64
Income Tax Expense	46.94	26.58	45.66	59.16	64.52
Earnings From Continuing Operations	486.71	506.11	426.11	362.07	347.11
Minority Interest in Earnings	-16.69	-9.59	-15.05	-13.53	-22.25
Net Income	470.02	496.51	411.06	348.55	324.86
Net Income to Common	470.02	496.51	411.06	348.55	324.86
Net Income Growth	-5.33%	20.79%	17.94%	7.29%	8.30%
Shares Outstanding (Basic)	681	674	661	627	622
Shares Outstanding (Diluted)	691	692	671	627	627
Shares Change (YoY)	-0.11%	3.20%	6.93%	-0.02%	0.86%
EPS (Basic)	0.69	0.74	0.62	0.56	0.52
EPS (Diluted)	0.68	0.72	0.61	0.56	0.52
EPS Growth	-5.56%	18.03%	9.75%	6.89%	8.33%
Free Cash Flow	155.19	-59.85	513.48	9.89	140
Free Cash Flow Per Share	0.23	-0.09	0.77	0.02	0.22
Dividend Per Share	-	0.250	0.200	0.150	0.150
Dividend Growth	-	25.00%	33.33%	-	25.00%
Gross Margin	24.11%	28.66%	26.50%	26.46%	29.33%
Operating Margin	7.04%	6.32%	6.21%	6.15%	7.64%
Profit Margin	5.55%	6.13%	5.48%	5.31%	5.41%
Free Cash Flow Margin	1.83%	-0.74%	6.84%	0.15%	2.33%
EBITDA	1,135	1,023	952.48	840.2	842.97
EBITDA Margin	13.41%	12.63%	12.70%	12.81%	14.04%
D&A For EBITDA	538.84	511.23	486.61	436.53	384.2
EBIT	596.33	512.15	465.87	403.67	458.77
EBIT Margin	7.04%	6.32%	6.21%	6.15%	7.64%
Effective Tax Rate	8.80%	4.99%	9.68%	14.04%	15.68%
Revenue as Reported	-	8,101	7,503	-	6,006
Advertising Expenses	-	8.95	8.18	11.33	12.84

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.